Latest Updates

Believes it will allow for better quality of clinical research in India and benefit patients

The portfolio being acquired comprises complex generic products across diverse dosage forms

Industry experts give their viewpoint on key taxation reform bill GST

Winner in the ‘Healthcare’ and ‘Not-For-Profit’ category

The two companies align to provide capabilities and solutions to deliver end-to-end support for renal disease clinical trials

The Lexington site capabilities and capacity would be expanded for commercial aseptic manufacturing

The commercial launch of these tablets in the US is expected over the next few weeks

Galvani will develop miniaturised, implantable devices that can modify electrical nerve signals to modulate irregular or altered…

With this acquisition, Kyowa will rank sixth amongst generic companies in Japan

Acquires controlling interest in Nashik-based Klasspack